secwatch.observer — SEC 8-K summary
======================================

Issuer:     Boundless Bio, Inc. (BOLD)
CIK:        0001782303
Form:       8-K
Filed at:   2024-08-20T23:59:59+00:00
Accession:  0000950170-24-099185
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Boundless Bio reprices options for execs to $3.56; CEO Hornby holds 1.15M repriced options
--------------------------------------------------------------------------------

- Exercise price reduced to $3.56 (Aug 19, 2024 close) for options originally priced at or above $3.71.
- Repriced options may only be exercised at the lower price if held through the Premium End Date (Aug 19, 2026, or earlier change in control or qualifying termination).
- CEO Zachary D. Hornby: 1,147,242 options repriced (original exercise range $4.10–$16.00).
- CMO Klaus Wagner: 316,893 options; CSO Chris Hassig: 292,821 options repriced.
- Repricing intended to retain key employees without incurring dilution from additional equity grants or cash compensation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1782303/000095017024099185/0000950170-24-099185-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1782303/000095017024099185/bold-20240819.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-099185

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer